News | November 21, 2023
AstraZeneca launches health-tech business ‘Evinova’
Evinova will operate as a separate health-tech business within AstraZeneca
Evinova will operate as a separate health-tech business within AstraZeneca
Phase 3 data expected in the second half of 2024
VaxTRIALS Adds a New Latin America Base and Greater Vaccine Research Depth
His M&A background and experience with successful private-equity-backed companies will benefit the company’s growth and diversification strategy
Ronco succeeds Dr. Christine Dingivan, who will now serve as a senior advisor to Executive Chairman Sastry Chilukuri
Appointment further strengthens company’s expertise in fastest-growing therapeutic area to meet patient need
India will account for about 18% of the Asia-Pacific (APAC) MRI systems market in 2023
Collaboration combines clinical research expertise with artificial intelligence capabilities to help drug developers better understand the probability of clinical success for their assets
Preclina is renowned for its highly specialized services in autoimmune and inflammatory disorders
The Long-term Safety Trial was approved to be conducted by China National Medical Products Administration (NMPA) on 18 April 2023
Subscribe To Our Newsletter & Stay Updated
